Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Receivables (2016 - 2026)

Orthopediatrics has reported Receivables over the past 11 years, most recently at $54.4 million for Q1 2026.

  • For Q1 2026, Receivables rose 23.72% year-over-year to $54.4 million; the TTM value through Mar 2026 reached $54.4 million, up 23.72%, while the annual FY2025 figure was $55.1 million, 26.33% up from the prior year.
  • Receivables for Q1 2026 was $54.4 million at Orthopediatrics, down from $55.1 million in the prior quarter.
  • Over five years, Receivables peaked at $55.1 million in Q4 2025 and troughed at $17.9 million in Q1 2022.
  • A 5-year average of $38.6 million and a median of $37.6 million in 2023 define the central range for Receivables.
  • On a YoY basis, Receivables climbed as much as 51.18% in 2022 and fell as far as 8.22% in 2022.
  • Year by year, Receivables stood at $26.0 million in 2022, then skyrocketed by 37.69% to $35.9 million in 2023, then increased by 21.58% to $43.6 million in 2024, then increased by 26.33% to $55.1 million in 2025, then dropped by 1.19% to $54.4 million in 2026.
  • Business Quant data shows Receivables for KIDS at $54.4 million in Q1 2026, $55.1 million in Q4 2025, and $51.3 million in Q3 2025.